ASPAVELI sol perf 1080 mg/20ml flac 20 ml
7680686740013
CH-68674
L04AJ03
07.15.0.
Reimbursement limitations:
ASPAVELI.01
Traitement des adultes atteints d’hémoglobinurie paroxystique nocturne (HPN)
Avant le début du traitement, une garantie …
1 / 3
google
Details
- Product number
- 6867401
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- pegcetacoplanum 54 mg, sorbitolum 41 mg, acidum aceticum glaciale, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum glaciale, aqua ad iniectabile, ad solutionem pro 1 ml corresp. natrium 0.37 mg.
Articles (1)
Aspaveli, Infusionslösung
Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
54.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
41.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.37 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 2971.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2023
Authorization holder
Swedish Orphan Biovitrum AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 68674
- Drug name
- Aspaveli, Infusionslösung
- Galenic form
- LSINF
- ATC Code
- L04AJ03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 23/03/2023
- Authorization expiration date
- 22/03/2028
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ASPAVELI sol perf 1080 mg/20ml flac 20 ml
- Description (DE)
- ASPAVELI Inf Lös 1080 mg/20ml Durchstf 20 ml
- Market launch
- 23/03/2023
- Narcotic (BTM)
- No